Endocrine Society members elected Joy Wu, MD, PhD, of the Stanford University School of Medicine in Stanford, Calif., as its 2027 – 2028 President. She will serve as president-elect for a year beginning in June 2026 before becoming president in June 2027.
Wu is the Gerald M. Reaven, MD Professor of Endocrinology, chief of the Division of Endocrinology and vice chair of basic science in the Department of Medicine at Stanford. She is a board-certified endocrinologist who specializes in treating osteoporosis and other bone and mineral diseases. She has a special interest in optimizing skeletal health for those at risk of bone loss from cancer therapies.
Wu directs a basic and translational research program that focuses on skeletal development and the bone marrow hematopoietic niche. Her laboratory is currently studying stem cell therapies for bone formation, and the prevention of cancer metastases to bone.
She is an active member of the Endocrine Society who has served on the Society’s Board of Directors as well as several committees and task forces. She was a member of the Society’s Hypercalcemia of Malignancy Guideline Writing Committee and currently serves on its Bone and Mineral Special Interest Group.
Wu will begin her term as President-Elect following ENDO 2026, the Society’s annual meeting taking place June 13-16, 2026, in Chicago, Ill.
Read more about Wu and her career in the Endocrine News May 2024 cover story, “The Joy of Endocrinology.”
Loading ...